UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 23, 2014 (July 17, 2014)
QUOTIENT LIMITED
(Exact name of registrant as specified in its charter)
Jersey, Channel Islands | 001-36415 | Not Applicable | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
Pentlands Science Park Bush Loan, Penicuik, Midlothian EH26 OPZ, United Kingdom |
Not Applicable | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: 011-44-0131-445-6159
n/a
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry into a Material Definitive Agreement
The dispute between our Alba subsidiary and Scottish National Blood Transfusion Service, or SNBTS, referenced in our Form 10-K for the year ended March 31, 2014 was settled on July 17, 2014 through an agreement between the parties. In the agreement, we extended the lease term for our manufacturing facility in Edinburgh, Scotland, where SNBTS is landlord, for a two-year period until August 31, 2016. In exchange, we agreed to pay SNBTS two annual payments of £112,000, or approximately $190,000 at current exchange rates. No other sums are payable by us to SNBTS in relation to the settlement of this dispute.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
QUOTIENT LIMITED | ||
By: |
/s/ Stephen S. Unger | |
| ||
Name: Stephen S. Unger | ||
Title: Chief Financial Officer |
Date: July 23, 2014